Guanylyl cyclase-activating proteins (GCAPs) are calcium sensor proteins of the EF-hand superfamily that inhibit retinal photoreceptor membrane guanylyl cyclase (retGC) in the dark when they bind Ca 2؉ but activate retGC when Ca 2؉ dissociates from GCAPs in response to light stimulus. We addressed the difference in exposure of GCAP-2 structure to protein kinase and a protease as indicators of conformational change caused by binding and release of Ca 2؉ . We have found that unlike its homolog, GCAP-1, the C terminus of GCAP-2 undergoes phosphorylation by cyclic nucleotidedependent protein kinases (CNDPK) present in the retinal extract and rapid dephosphorylation by the protein phosphatase PP2C present in the retina. Inactivation of the CNDPK phosphorylation site in GCAP-2 by substitutions S201G or S201D, as well as phosphorylation or thiophosphorylation of Ser 201 , had little effect on the ability of GCAP-2 to regulate retGC in reconstituted membranes in vitro. At the same time, Ca 2؉ strongly inhibited phosphorylation of the wild-type GCAP-2 by retinal CNDPK but did not affect phosphorylation of a constitutively active Ca 2؉ -insensitive GCAP-2 mutant. Partial digestion of purified GCAP-2 with Glu-C protease revealed at least two sites that become exposed or constrained in a Ca 2؉ -sensitive manner. The Ca 2؉ -dependent conformational changes in GCAP-2 affect the areas around Glu 62 residue in the entering helix of EFhand 2, the areas proximal to the exiting helix of EF-hand 3, and Glu 136 -Glu 138 between EF-hand 3 and EF-hand 4. These changes also cause the release of the C-terminal Ser 201 from the constraint caused by the Ca 2؉ -bound conformation.
Photoisomerized rhodopsin triggers hydrolysis of cGMP through the activation of the G-protein transducin, which stimulates cGMP phosphodiesterase and thus causes cGMPgated channels to close (see Refs. 1-3 for review). Rods and cones rapidly recover to their resting potential after excitation induced by a brief non-saturating exposure to light. They also adapt to a constant background illumination by decreasing the amplitude and accelerating the kinetics of their electrical responses to a standard test flash (see Refs. 1-3 for review). Reopening of the cGMP-gated channels during recovery and light adaptation requires acceleration of cGMP synthesis by guanylyl cyclase, a process controlled by the level of intracellular free Ca 2ϩ . In the dark, Ca 2ϩ extruded from the photoreceptor outer segment by a Na ϩ /K ϩ ,Ca 2ϩ exchanger re-enters the outer segment through the open cGMP-gated channels so that the free intracellular outer segment Ca 2ϩ concentrations reach 250 nM in mammals and 350 -450 nM in lower vertebrates (4 -6) . In the light, cGMP is hydrolyzed, and these channels close while the exchanger continues to extrude Ca 2ϩ ions from the photoreceptor outer segment; therefore, Ca 2ϩ concentrations decrease nearly 10-fold (4 -7). Ca 2ϩ -binding proteins GCAP-1 1 and GCAP-2 activate retGC1 and retGC2 (and their homologs found in photoreceptors of different vertebrate species) in a Ca 2ϩ -sensitive manner (see Refs. 8 -11 for review). GCAPs are a separate subfamily within the broader family of neuronal calcium sensor proteins that includes many recoverin-like proteins. The recoverin-like neuronal calcium sensor proteins have four EF-hand-type Ca 2ϩ -binding domains and an Nterminal Gly residue acylated with fatty acid residues. Only three of the EF-hand structures in GCAPs are true Ca 2ϩ -binding domains in which Ca 2ϩ sensitivity is adjusted to the range within which the intracellular free Ca 2ϩ varies between light and dark by intracellular free Mg 2ϩ (12) . The N-terminal EF-hand-related motif EF-1 cannot bind Ca 2ϩ but strongly contributes to the GCAP interaction with retGC (13, 14) .
The partial solution structure of the Ca 2ϩ -bound GCAP-2 established by Ames et al. (15) resembles those of recoverin and neurocalcin and consists of two globular halves connected by a flexible "hinge" region. The NMR structure was established only for the Ca 2ϩ -loaded form of GCAP-2 and does not include the C-terminal portion of the protein; therefore, the exact conformational changes that occur when dissociation of the Ca 2ϩ ions causes GCAP-2 to transition into the activator conformation are not immediately apparent.
In our present study, we used the accessibility for the CNDPK phosphorylation of a Ser 201 residue proximal to the C terminus of GCAP-2 and limited proteolysis by protease V8 to assess the conformational changes in GCAP-2 related to the binding and release of Ca 2ϩ . Our data indicate that the C terminus of GCAP-2 undergoes a conformational Ca 2ϩ -dependent switch that releases the C terminus from a constraint created by the Ca 2ϩ -loaded structure of GCAP-2 and changes the exposure of the regions between EF-hands 2 and 3 and between EF-3 and -4.
EXPERIMENTAL PROCEDURES
Cyclic Nucleotide-dependent Protein Kinases-Purified cGMPdependent kinase II (PKG II) and cAMP-dependent protein kinase (PKA) were kindly provided by Dr. Michael Uhler (University of Michigan). Purified cGMP-dependent protein kinase isoform I␣ (PKG I␣) was from Calbiochem/EMD (San Diego, CA).
Recombinant myristoylated bovine and mouse GCAP-2, GCAP-1, and neurocalcin were expressed from pET11d vector (Novagen/EMD) in a BLR(DE3)pLysS Escherichia coli strain harboring yeast N-myristoyltransferase and purified as described previously in full detail (12, 16, 17) .
Site-directed Mutagenesis-All mutations were incorporated into bovine GCAP-2 cDNA by PCR using the splicing by overlap extension technique and Pfu DNA polymerase (Stratagene) as described previously (18, 19 43, 31, 21, 14 , and 6 kDa. The position of GCAPs in the gel is indicated by the asterisk. The minor band, ϳ1 kDa above the main GCAP band, in every case corresponds to non-myristoylated GCAP. The 50-l reaction mixture contained purified PKG I␣ (1,000 units, Calbiochem), 40 g of bovine serum albumin, and 20 g of purified recombinant WT GCAP-2 (b and c), partially purified C⌬1GCAP-2 mutant (d), or purified recombinant GCAP-1 (e). c-e, 150 M cGMP was added; b, no cGMP added. After incubation for 30 min at 37°C, each reaction mixture was diluted with Laemmli buffer, and 20 l were loaded on SDS-PAGE and analyzed as described under "Experimental Procedures." C, lack of PKG I␣-dependent phosphorylation in GCAP-2 with Ser 201 substituted by Asp (a) or Gly (b). c, non-substituted Ser 201 GCAP-2 as a control. D, radioautograph of WT GCAP-2 phosphorylated in vitro by 1 l each of PKG II (a), PKA (b), and PKG Ia (c). E, radioautograph of recombinant GCAP-2 phosphorylated by soluble retinal CNDPK in retinal extract as a function of Mg 2ϩ concentration. a-e, 1.5 g of WT GCAP-2; f-i, 1 g of C⌬1GCAP-2. The reaction contained 10 l of retinal S 100 fraction and 100 M 8-Br-cGMP. F, GCAP-2 phosphorylation by S 100 soluble retinal fraction requires cyclic nucleotide. A radioautograph of 1 g of WT GCAP-2 phosphorylated in the presence of 10 l of S 100 fraction in the presence (a) or in the absence (b) of 100 M 8-Br-cGMP is shown. c, no exogenous GCAP-2 was added. d, purified [ 32 P]GCAP-2 labeled in vitro by PKG I␣, as in A, used as a protein marker. G and H, PKG I-dependent phosphorylation does not affect electrophoretic mobility of bovine or mouse GCAP-2. G, bovine GCAP-2 (2 g) that contains 50% phosphorylated myristoylated GCAP-2 migrates as a single band (b). The extent of GCAP-2 phosphorylation by PKG I was determined from the specific activity of the 32 P label incorporated into 75 M GCAP-2 from 0.75 mM ATP containing 10 Ci of [␥-an SEQ 4 ϫ 4 automated sequencer (Amersham Biosciences). The C⌬1GCAP-2 mutant lacked the last nine amino acid residues. The Ca 2ϩ -insensitive GCAP-2, EF2/3/4, contains single substitutions in all three EF-hands that prevented high-affinity Ca 2ϩ binding and was expressed and purified as described previously in detail (18, 19) .
Photoreceptor outer segment membranes were isolated under infrared illumination from frozen dark-adapted bovine retinas (Lawson and Lawson) using sucrose density gradient centrifugation and were washed in low salt buffer to remove endogenous GCAPs as described previously (12, 16) . Soluble Retinal Extract (S 100 )-Fresh bovine eyes obtained at a local slaughterhouse were dark-adapted for 2 h on ice, dissected under infrared light, and homogenized in 0.5 ml of buffer A (5 mM sodium phosphate buffer, pH 7.2, 50 mM NaCl) per retina on ice by 10 strokes in a Dounce homogenizer. The homogenate was centrifuged at 20,000 ϫ g at 4°C, and the supernatant was collected and centrifuged in 200-l aliquots in a Beckman A100 rotor for 30 min at 80,000 rpm. The supernatant fraction, S 100 , was collected and used immediately or divided into aliquots, frozen in dry ice, and stored at Ϫ70°C. Typical total protein concentration in the S 100 fraction was near 40 mg/ml Phosphorylation Assay-Unless indicated otherwise, a typical phosphorylation reaction contained 30 mM Tris/HCl, pH 7.5, 5 mM MgCl 2 , 5 mM sodium phosphate buffer, pH 7.5, 6 mM dithiothreitol, 0.1 mM EGTA, 10 M ATP or 10 M ATP␥S (Sigma), ϳ10 Ci of [ 32 P]-or [ 35 S]ATP␥S (PerkinElmer Life Sciences), and 300 M 8-Br-cGMP (Sigma). After incubation at 37°C, the reaction was stopped by adding 2 volumes of a Laemmli sample SDS buffer containing 4 mM EGTA and was boiled for 5 min. Phosphorylated proteins were then separated by SDS-PAGE in 15% polyacrylamide gel, fixed in 7.5% acetic acid, 10% methanol solution, stained with Coomassie Blue, destained in 7.5% acetic acid, 10% methanol, and covered with thin polyethylene film exposed on Kodak Bio Max or X-Omat AR at room temperature. Adding EGTA in the sample buffer was required to prevent the appearance of multiple bands of GCAPs because of Ca 2ϩ binding during PAGE.
The thiophosphorylation reaction contained 50 mM Tris/HCl, pH 7.6, 2 mM EGTA, 5 mM MgCl 2 , 0.5 mM 8-Br-cGMP, 10 g/ml leupeptin, 20,000 units of PKG I␣, 5.0 mM ATP␥S, and 60 M GCAP-2. The reaction was incubated at 23°C for 2 h and then incubated overnight at 4°C. After incubation, the reaction mixture was dialyzed against 10 mM Tris/HCl, pH 7.5.
Protein Phosphatase Assay-Wild-type GCAP-2 was 32 P-labeled in the presence of PKG I␣ as described above, except instead of quenching the reaction by adding SDS sample buffer, the unincorporated label was removed by gel filtration on Sephadex G-50. The phosphatase reaction typically contained 1 g of [ 32 P]GCAP-2 (ϳ1 Ci/g), 10 l of S 100 protein fraction in 5 mM MgCl 2 , 20 mM Tris 7.5, and 6 mM dithiothreitol in a total volume of 20 l. Fenvalerate, okadaic acid, and microcystine were added from 100ϫ concentrated stock solution in Me 2 SO, and the corresponding volume of Me 2 SO was added in control samples even though Me 2 SO had no noticeable effect on the phosphatase activity because of low concentrations. After incubation at 37°C for 15 min. the reaction was stopped by adding 2 volumes of a Laemmli sample SDSbuffer containing 4 mM EGTA and was boiled for 3 min followed by SDS-PAGE and radioautography as described above.
Immunoblot-Proteins were transferred from SDS-polyacrylamide gel onto Immobillon P membrane (Millipore) for 20 h at 60 V, stained for GCAP-2 using polyclonal rabbit antibody ⌬NP24 (20) , and developed using alkaline phosphatase-conjugated goat anti-rabbit IgG (ICN/Cappel).
Glu-C Proteolysis-The reaction contained 20 l of 10 mM Tris/HCl, pH 7.5, 10 mM 2-mercaptoethanol, either 500 M CaCl 2 or 100 M EDTA, 46 g of purified GCAP-2, and 0.18 g of Staphylococcus aureus protease V8 (Sigma). The components were mixed at room temperature and incubated for 7 min at 37°C, and the reaction was stopped by heating to 100°C for 5 min. 10-l aliquots from each reaction were then loaded on a capillary C4 column. Peptides eluted with a gradient of acetonitrile in 0.05% trifluoroacetic acid were directly infused into a Sciex API III electrospray mass spectrometer and scanned for positive ions with m/z values between 600 and 1200. Mass spectrometry data were processed using Sciex MacProMass and MacSpec software.
RetGC Assay-All experiments were conducted under infrared light as described (12) . The assay mixture (25 l) contained 30 mM MOPS/ KOH, pH 7.2, 60 mM KCl, 5 mM NaCl, 1 mM dithiothreitol, 2 mM Ca 2ϩ /EGTA buffer, 1 mM free Mg 2ϩ , zaprinast and dipyridamole (25 M each), leupeptin and aprotinin (10 g/ml each), 0.3 mM ATP, 4 mM cGMP, 1 mM GTP, ϳ1 Ci of [␣-
32 P]GTP, 0.1 Ci of [8-3 H]cGMP, 1 l of washed bovine outer segment membranes (3.7 mg/ml rhodopsin), and purified recombinant GCAP-2 or its mutants as indicated in the figure legends. The products of the reaction were analyzed by TLC using fluorescent plastic polyethyleneimine cellulose as described (17) . Ca 2ϩ /EGTA buffers were prepared as described (21), and the final free Ca 2ϩ and Mg 2ϩ concentrations in the reaction mixture were calculated using the algorithm of Marks and Maxfield (22) . Ca 2ϩ /EGTA buffers were calibrated using Ca 2ϩ fluorescence dyes Fluo-3 and X-rhod FF (K d of 325 nM and 17 M, respectively) (Molecular Probes, Eugene, OR).
RESULTS AND DISCUSSION
According to the NMR spectroscopy study by Ames et al. (15) , the overall folding of Ca 2ϩ -loaded GCAP-2 resembles recoverin, 
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a Ca 2ϩ -binding protein that affects rhodopsin kinase activity (23) and neurocalcin (24) . All attempts to solve the threedimensional structure of the Ca 2ϩ -free activator form of GCAP-2 were unsuccessful, so there is no direct structural information available on how Ca 2ϩ release or binding can trigger conformational changes in the GCAP-2 molecule. Moreover, the C-terminal portion of GCAP-2 was not resolved in the NMR structure of Ca 2ϩ -loaded GCAP-2. Reversible dimerization of Ca 2ϩ -free GCAP-2 (25) poses an additional challenge for the study because binding and release of Ca 2ϩ not only affects the conformation of GCAP-2, but also alters GCAP-2/GCAP-2 interaction. To assess the possible structural change between Ca 2ϩ -bound and Ca 2ϩ -free GCAP-2, we studied the effects of Ca 2ϩ on site-specific phosphorylation and limited proteolysis of GCAP-2.
C-terminal Ser 201 in GCAP-2 Undergoes Phosphorylation by CNDPK
The RRKSAMF sequence at the C terminus of the GCAP-2 molecule (20) is a typical consensus recognition site for both cGMP-and cAMP-dependent kinases, so three different purified CNDPKs can phosphorylate the C-terminal Ser in GCAP-2 in vitro (Fig. 1, A-D) . Purified PKG I phosphorylates GCAP-2 with low efficiency in the absence of added cyclic nucleotide, and the addition of cGMP enhances the phosphorylation (Fig.  1B, lanes b and c) . GCAP-1 lacks such a sequence (26) , and we did not observe phosphorylation of GCAP-1 by CNDPK under the same conditions (Fig. 1, A and B, lane e) . Unlike wild-type GCAP-2, a chimera mutant, in which the C-terminal region downstream of EF-4 was substituted with the corresponding fragment from the related recoverin-like protein neurocalcin (19), did not undergo phosphorylation under these conditions (not shown). Deletion (mutant C⌬1) of the last nine amino acid residues, including Ser 201 , from GCAP-2 (19) also completely abolished phosphorylation (Fig. 1, A and B, lane d) . Apparently, the C terminus in GCAP-2 was the only part in GCAP-2 that was phosphorylated. To ensure that the CNDPK site Ser 201 was the only site of phosphorylation in GCAP-2, we substituted Ser 201 with either Gly or Asp and found that both mutations completely abolished 32 P incorporation in GCAP-2 (Fig. 1C) . In the presence of N-myristoyltransferase, GCAP-2 is expressed in E. coli predominantly as a fatty acylated protein (16); however, a variable small fraction of GCAP-2 that remains non-acylated is often present in such preparations and appears in SDS-PAGE as a minor band just above the acylated GCAP-2 (16). When both myristoylated and non-myristoylated forms are present in preparation of GCAP-2, they incorporate the 32 P label catalyzed by purified PKA and PKG (Fig. 1D) . Hence, myristoylation is not required for GCAP-2 to become a substrate for CNDPK.
PKA, PKG II, and, at a lower level, PKG I have been reported in photoreceptors (27, 28) . Consistent with that report, we have found that the retinal extract contains soluble GCAP-2 kinase activity stimulated by cGMP or its slow hydrolyzable analog, 8-Br-cGMP (Fig. 1, D and F) . To minimize potential interference from phosphorylation of the endogenous GCAP-2, we extracted soluble retinal proteins (S 100 fraction) at normal ionic strength when GCAP-2 remained mostly associated with the membrane fraction (16) . Although the S 100 fraction contains an ϳ33-kDa endogenous protein (presumably phosducin) that is highly phosphorylated by the CNDPK (27, 29) , this band migrates substantially higher than GCAP-2 and therefore does not interfere with the analysis. Using 8-Br-cGMP produces more stable and reproducible results because the S 100 fraction, even isolated from the dark-adapted retina, contains substantial traces of cGMP phosphodiesterase activity (not shown). In the presence of cyclic nucleotide, purified recombinant GCAP-2 becomes phosphorylated by the S 100 fraction. The Ser 201 in GCAP-2 was the only site for the protein kinase activity present in the S 100 fraction, and it was phosphorylated only by CNDPK. Removing the CNDPK site from GCAP-2 either by deletion or a by the point mutation S201D (Fig. 1, C and E) completely suppresses phosphorylation of GCAP-2 by the retinal extract, as does the removal of CNDPK activator (Fig. 1F) . Although in other proteins phosphorylation can alter their electrophoretic mobility, phosphorylation of Ser 201 in GCAP-2 (either of bovine or mouse origin) does not affect its electrophoretic mobility in denaturing SDS gel (Fig. 1, G and H) .
Dephosphorylation of GCAP-2-GCAP-2 can be phosphorylated by CNDPK present in the S 100 fraction, but the efficiency of phosphorylation in that case is drastically lower (Ͼ10-fold lower, data not shown) compared with purified CNDPK because the S 100 fraction also contains a protein phosphatase (Fig. 2) . Purified 32 P-labeled GCAP-2, phosphorylated by PKG I␣ and added to the retinal S 100 fraction, becomes rapidly dephosphorylated (Fig. 2, A and D) . The loss of radioactivity was due to phosphatase activity, not protein degradation, because leupeptin and aprotinin did not prevent the loss of the 32 P label from prephosphorylated GCAP-2 (not shown), and the integrity of GCAP-2 was not compromised after incubation with S 100 (Fig. 2B) .
Inhibitors of protein phosphatases PP1, PP2A, and PP2B (such as Fenvalerate, microcystine, and okadaic acid) do not affect dephosphorylation of [ 32 P]GCAP-2, even at concentrations high enough to completely inhibit these protein phosphatases (Fig. 2) . Similarly, neither bromotetramisole (an alkaline phosphatase inhibitor) nor the removal of Ca 2ϩ by EGTA inhibits dephosphorylation. Inhibition of the [ 32 P]G-CAP-2 dephosphorylation occurred only when Mg 2ϩ was removed from the reaction mixture by EDTA. EDTA is the only inhibitor of the fourth type of protein phosphatase, the Mg 2ϩ -dependent phosphatase PP2C, which is also present in the retina (30) (Fig. 2, A, C, and D) . Phospho-GCAP-2 appears to be the first PP2C-specific substrate identified in photoreceptors. The only covalent modification in GCAP-2 isolated from bovine retinas was fatty acylation (16) , and the presence of potent phosphatase PP2C in retinal extract (30) may account for the lack of phosphorylated GCAP-2 after its isolation from the retina. Therefore, it remains unclear to what extent GCAP-2 can be phosphorylated in vivo.
Phosphorylation of GCAP-2 and RetGC Regulation
ATP is known to potentiate the stimulation of retGC by GCAP-2 in vitro (31-34). The light-activated photoreceptorspecific phosphodiesterase PDE6 can hydrolyze both cGMP and cAMP, and Ca 2ϩ -dependent regulation of adenylyl cyclase can regulate cAMP levels in rods (29, 35, 36) . Therefore, either PKA or PKG could potentially affect retGC activity or Ca 2ϩ sensitivity via phosphorylation of GCAP-2. However, neither inactivation of the phosphorylation site in GCAP-2 ( Fig. 3) nor inclusion of CNDPK and its activators directly into the retGC assay reaction (not shown) had an effect on retGC regulation. Only a small change (Ͻ15%) in maximal activity of retGC was observed when Ser 201 was substituted with either Gly or negatively charged Asp residues. Yet the potentiating effect of ATP on retGC activity remained present in both GCAP-2 mutants (Fig. 3) . To completely exclude the possibility that PP2C, which is present in outer segment membranes, interferes with the analysis, we used modification by a thiophosphate group that can be transferred to proteins by protein kinases but cannot be removed by protein phosphatases. Prior to use in retGC assay, GCAP-2 was incubated with PKG I␣ and ATP␥S, after which 92% of GCAP-2 became unavailable for subsequent phosphorylation using [␥-32 P]ATP (Fig. 4A) . Neither the affinity for guanylyl cyclase nor the Ca 2ϩ sensitivity of the cyclase regulation by GCAP-2 changed after the Ser 201 thiophosphorylation of GCAP-2 (Fig. 4, A and B) . Apparently, the effect of ATP on retGC activation is because of either ATP binding by retGC (33) or phosphorylation of retGC itself (37) but not because of phosphorylation of GCAP-2. Phosphorylation by PKG does not affect Ca 2ϩ -sensitive dimerization of GCAP-2 either (25) (Fig. 4,  C and D) . Distribution of [ 32 P]GCAP-2 in the fractions eluted from the gel filtration column demonstrates that the amount of radioactivity follows the protein profiles. The phosphorylated GCAP-2 elutes predominantly as a monomer in the presence of Ca 2ϩ but distributes almost equally between the monomer and the dimer in the presence of EGTA.
This result is consistent with our previous observation that small C-terminal deletions in GCAP-2 have only a minor effect on retGC activation (19) and argues against GCAP-2 The optical density of bands on the radioautograph from independent measurements using scanning densitometer and MultiAnalyst software is plotted relative to the density of the GCAP-2 band produced in the sample containing EGTA.
phosphorylation playing a part in retGC regulation. Yet we cannot exclude the possibility that phosphorylation contributes to processes other than GCAP-2/retGC interaction because the C-terminal CNDPK site is preserved in all vertebrate species (38) .
Conformational Change in GCAP-2 as a Function of Ca 2ϩ Binding
Our preliminary experiments indicated that phosphorylation of Ser 201 in GCAP-2 by the retinal CNDPK was suppressed when concentrations of free Ca 2ϩ were above 1 M in the reaction mixture (not shown). However, the efficiency of GCAP-2 phosphorylation by the crude retinal CNDPK is dramatically influenced by PP2C activity present in the retinal extract, which can potentially interfere with the interpretation of these data. Therefore, to avoid interference from the PP2C activity, we used [
35 S]ATP␥S. Protein kinases can efficiently utilize this ATP analog as a substrate, whereas the resulting thiophosphoprotein is not recognized by protein phosphatases (39) . By using this approach we found that retinal CNDPK indeed phosphorylates GCAP-2 in a Ca 2ϩ -sensitive manner (Fig. 5) . GCAP-2 fully saturates with Ca 2ϩ when free Ca 2ϩ concentrations are above 1 M, even in the presence of 5 mM MgCl 2 (12, 15) . The saturating free Ca 2ϩ concentrations suppress GCAP-2 thiophosphorylation by the soluble retinal CNDPK (Fig. 5A, lanes a and b) . S201D GCAP-2 was used as a control for the CNDPK-specific site (Fig. 5A, lane c) , and both thiophosphorylation and phosphorylation of GCAP-2 by purified CNDPK were also inhibited (Fig. 5, B and C) . In different experiments, the relative efficiency of the retinal CNDPK-dependent phosphorylation for the Ca 2ϩ -loaded GCAP-2 varied between 6 and 40% compared with the Ca 2ϩ -free GCAP-2, and on average, phosphorylation of the Ca 2ϩ -bound GCAP-2 was suppressed nearly 5-fold (Fig. 5D) .
Was the effect of Ca 2ϩ because of a change in the specificity of the CNDPK activity or the result of a conformational change in GCAP-2? To answer this question, we used the constitutively active GCAP-2 mutant EF2/3/4 (18) . This mutant remains constitutively active even in the presence of Ca 2ϩ , because inactivation of all three active EF-hands by substitutions in the first or the last amino acid residues of a 12-amino acid Ca 2ϩ -binding loop of the EF-hands 2, 3, and 4 locks GCAP-2 in a Ca 2ϩ -free conformation (18) . If the effect of Ca 2ϩ was because of changes in CNDPK activity and specificity rather than related confor- 
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mational changes in GCAP-2, then phosphorylation of the constitutive EF2/3/4 GCAP-2 ought to be as Ca 2ϩ -sensitive as the wild-type GCAP-2. Conversely, if the effect of EGTA and Ca 2ϩ on the phosphorylation of GCAP-2 by CNDPK resulted mainly from the change in exposure of the Ser 201 as a substrate for CNDPK, Ca 2ϩ should have had, in contrast to wildtype GCAP-2, little effect on phosphorylation of the EF2/3/4 GCAP-2. Indeed, unlike the wild type, the constitutively active GCAP-2 mutant was equally well phosphorylated at both low and high Ca 2ϩ concentrations (Fig. 5A, lanes d and e, and Fig.  5C, lanes c and d) . We therefore conclude that the effect of Ca 2ϩ on GCAP-2 phosphorylation directly reflects the difference in exposure of the Ser 201 rather than the change in CNDPK activity by Ca 2ϩ . To detect other major changes in GCAP-2 caused by binding and release of Ca 2ϩ , we performed partial proteolytic digestion of GCAP-2 by S. aureus protease V8. This was performed when Ͻ50% of the full-length protein underwent proteolytic cleavage. The products of the reaction were analyzed by liquid chromatography electrospray ionization mass spectroscopy (Fig. 6) . We found major difference for the two sets of products with regard to Ca 2ϩ sensitivity. The set of fragments generated by the cleavage of Glu 136 or Glu 138 and found in the presence of Ca 2ϩ was virtually undetectable among the products of proteolysis of the Ca 2ϩ -free GCAP-2. These results indicate that the region between EF-hand 3 and EF-hand 4 (Fig. 7) becomes less constrained when EF-hands are filled with Ca 2ϩ . In contrast, the Glu 62 located in the entering alpha helix of EF-hand 2 is only exposed when GCAP-2 undergoes the transition into its Ca 2ϩ -free (cyclase activator) conformation. The three possible scenarios through which Ca 2ϩ may affect the exposure of the parts of GCAP-2 are discussed in the following paragraphs.
Compartmentalization-GCAP-2 could associate with the membrane and/or the target cyclase in such a manner that in the Ca 2ϩ -bound form, the C terminus is protected from phosphorylation by proximity to the membrane. However, we are justified in ruling out this possibility because (a) the GCAP-2 phosphorylation and proteolysis experiments described in this paper were carried out using only soluble protein, and (b) Ca 2ϩ -loaded GCAP-2 tends to dissociate from the membrane more efficiently than the Ca 2ϩ -free form (16) . Ca 2ϩ -dependent Association of GCAP-2-Ca 2ϩ -dependent association of GCAP-2 with unknown soluble retinal protein(s) could hamper its interaction with CNDPK. This possibility cannot be completely ruled out in the case of a complex protein mixture such as the S 100 fraction. Yet it remains highly unlikely, because we observed Ca 2ϩ sensitivity of GCAP-2 phosphorylation even by purified CNDPK in the absence of other proteins in the reaction (Fig. 5, B and C) . Therefore, the change in availability of the C-terminal Ser 201 as a substrate for CNDPK reflects its constraint in the Ca 2ϩ -bound form and its release from constraint in Ca 2ϩ -free GCAP-2 ( Fig. 7A) . Dimerization of GCAP-2-The Ca 2ϩ -free form of GCAP-2 can undergo dimerization, and the dimer dissociates upon its transition back into the Ca 2ϩ -loaded retGC inhibitor form (13, 25) . Obviously, the exposure of some regions of the main and side chains in GCAP-2 can be affected by the GCAP-2 dimerization. In particular, the flexible portion of GCAP-2 structure between EF-hands 3 and 4 could become masked when it forms the Ca 2ϩ -free dimer. However, this seems an unlikely explanation, because even in the Ca 2ϩ -free form of GCAP-2, we observed a mixture of monomers and dimers at a nearly equal (or at least comparable) ratio. Should the Glu 136 -Glu 138 region become constrained only as a result of dimerization, we would still expect almost one-half of the protein to undergo cleavage at these sites. Yet unlike Ca 2ϩ -bound GCAP-2, none of the corresponding peptides was detectable in the case of the Ca 2ϩ -free GCAP-2 (Fig. 6, left panel) . Therefore, it is more reasonable to suggest that the flexible loop between EF-hands 3 and 4, well exposed in Ca 2ϩ -bound GCAP-2 structure (15), becomes constrained in both Ca 2ϩ -free monomers and dimers of GCAP-2. Even though dissociation of Ca 2ϩ promotes GCAP-2 dimerization (25) , its C-terminal Ser 201 becomes more accessible for the CNDPK (Figs. 5 and 7) .
In the case of recoverin, binding of Ca 2ϩ results in a calciummyristoyl switch, during which the fatty acylated N-terminal segment of the molecule undergoes a Ca 2ϩ -dependent extrusion from a hydrophobic pocket (40) . A similar process may also take place in the case of other recoverin-like proteins (24) . Yet, both functional and structural analyses of GCAP-2 strongly indicate that Ca 2ϩ -dependent conformational changes in GCAP-2 are different from recoverin and do not include the N-terminal Ca 2ϩ -myristoyl switch (16, 41) . Our data support the possibility that, instead, the C terminus in GCAP-2 undergoes a Ca 2ϩ -sensitive conformational switch. Although the flexibility and exposure of the C terminus is limited by the constraint created in the protein structure by Ca 2ϩ binding to EF-hands, the constraint at the C-terminal Ser 201 is released after dissociation of Ca 2ϩ from GCAP-2 (Fig. 7) . Hence, if a Ca 2ϩ -sensitive switch exists in GCAP-2, it is located at the C terminus of GCAP-2, which is opposite to the N-terminal Ca 2ϩ -myristoyl switch in recoverin that extrudes the N terminus of the protein when Ca 2ϩ is bound (42 (15) . The model was drawn using SPDB Viewer 3.7 software. Positions of Ca 2ϩ ions within the Ca 2ϩ -binding loops of EF-hands 2, 3, and 4 are shown as green spheres. C, Glu 62 , shown with space-filled atoms in the entering helix of EF-hand 2, is likely to move away from the exiting helix of EF-hand 3 in the absence of Ca 2ϩ and thus become exposed for proteolysis when GCAP-2 undergoes transition into the activator conformation.
does not show the presence of stable long-range interactions at the C terminus (amino acids 189 -204). This would indicate that the C terminus remains unstructured and flexible even in Ca 2ϩ -bound conformation, yet it is not extruded far enough from the protein core to become accessible for CNDPK.
Interestingly, neither the C terminus nor the flexible unstructured loop between EF-hands 3 and 4 observed in the NMR structure of Ca 2ϩ -bound GCAP-2 (15) is essential for retGC activation (19) , so their exposure or constraint reflects the overall conformational change in GCAP-2 rather than playing an important role in cyclase regulation. In contrast to that role, the region between EF-hands 2 and 3 in GCAPs apparently plays an essential role in retGC regulation (13, 19, 43, 44) , especially in the hinge region located between the exiting helix of EF-2 and the entering helix of EF-3 (15) . Because the Glu 62 residue located in the entering helix of EF-2 becomes exposed in Ca 2ϩ -free GCAP-2, the release of Ca 2ϩ most likely destabilizes the interaction between the entering helix of EF-2 and exiting helix of EF-3, potentially making the hinge region more accessible for external protein-protein interactions and/or reflecting a motion between the two globular parts of GCAP-2. It has also been speculated that such a motion takes place in GCAP-1 during binding and dissociation of Ca 2ϩ based on tryptophan fluorescence changes and tryptic digestion (45) (46) (47) . Also, in Ca 2ϩ -free recoverin, the entering helix of EF-2 is solvent-exposed and structurally unstable. By contrast, in Ca 2ϩ -bound recoverin, this helix becomes highly stabilized by its interaction with the helices of EF-3 at the domain interface (48, 49) . Similar Ca 2ϩ -induced changes may take place in GCAP-2.
